133 related articles for article (PubMed ID: 12846709)
1. Dolasetron for the prevention of postoperative vomiting in children undergoing strabismus surgery.
Wagner D; Pandit U; Voepel-Lewis T; Weber M
Paediatr Anaesth; 2003 Jul; 13(6):522-6. PubMed ID: 12846709
[TBL] [Abstract][Full Text] [Related]
2. Comparison of oral dolasetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in children.
Karamanlioglu B; Turan A; Memis D; Süt N
Eur J Anaesthesiol; 2003 Oct; 20(10):831-5. PubMed ID: 14580054
[TBL] [Abstract][Full Text] [Related]
3. Oral dolasetron mesylate for prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. The Oral Dolasetron PONV Prevention Study Group.
Diemunsch P; Korttila K; Leeser J; Helmers JH; Wilkey B; Navé S; Radke AJ; Hahne WF; Brown RA
J Clin Anesth; 1998 Mar; 10(2):145-52. PubMed ID: 9524901
[TBL] [Abstract][Full Text] [Related]
4. [Dolasetron, droperidol and a combination of both in prevention of postoperative nausea and vomiting after extracapsular cataract extraction under general anesthesia].
Eberhart LH; Lindenthal M; Seeling W; Gäckle H; Georgieff M
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Jun; 34(6):345-9. PubMed ID: 10429772
[TBL] [Abstract][Full Text] [Related]
5. Dolasetron for the prevention of postoperative nausea and vomiting following outpatient surgery with general anaesthesia: a randomized, placebo-controlled study. The Dolasetron PONV Prevention Study Group.
Philip BK; Pearman MH; Kovac AL; Chelly JE; Wetchler BV; McKenzie R; Monk TG; Dershwitz M; Mingus M; Sung YF; Hahne WF; Brown RA
Eur J Anaesthesiol; 2000 Jan; 17(1):23-32. PubMed ID: 10758440
[TBL] [Abstract][Full Text] [Related]
6. [Prophylaxis of nausea and vomiting after thyroid surgery: comparison of oral and intravenous dolasetron with intravenous droperidol and placebo].
Danner K; Becker HG; Best B; Madler C
Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jul; 36(7):425-30. PubMed ID: 11496617
[TBL] [Abstract][Full Text] [Related]
7. The effect of timing of dolasetron administration on its efficacy as a prophylactic antiemetic in the ambulatory setting.
Chen X; Tang J; White PF; Wender RH; Quon R; Sloninsky A; Naruse R; Kariger R; Webb T; Norel E
Anesth Analg; 2001 Oct; 93(4):906-11. PubMed ID: 11574355
[TBL] [Abstract][Full Text] [Related]
8. Pooled analysis of three large clinical trials to determine the optimal dose of dolasetron mesylate needed to prevent postoperative nausea and vomiting. The Dolasetron Prophylaxis Study Group.
Philip BK; McLeskey CH; Chelly JE; McKenzie R; Kovac AL; Diemunsch P; DuBois DM
J Clin Anesth; 2000 Feb; 12(1):1-8. PubMed ID: 10773500
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic oral dolasetron mesylate reduces nausea and vomiting after abdominal hysterectomy. The Canadian Dolasetron Study Group.
Warriner CB; Knox D; Belo S; Cole C; Finegan BA; Perreault L
Can J Anaesth; 1997 Nov; 44(11):1167-73. PubMed ID: 9398956
[TBL] [Abstract][Full Text] [Related]
10. Postoperative nausea and vomiting after surgery for prognathism: not only a question of patients' comfort. A placebo-controlled comparison of dolasetron and droperidol.
Piper SN; Röhm K; Boldt J; Kranke P; Maleck W; Seifert R; Suttner S
J Craniomaxillofac Surg; 2008 Apr; 36(3):173-179. PubMed ID: 18353666
[TBL] [Abstract][Full Text] [Related]
11. Treatment of postoperative nausea and vomiting with single intravenous doses of dolasetron mesylate: a multicenter trial. Dolasetron Mesylate PONV Treatment Study Group.
Kovac AL; Scuderi PE; Boerner TF; Chelly JE; Goldberg ME; Hantler CB; Hahne WF; Brown RA
Anesth Analg; 1997 Sep; 85(3):546-52. PubMed ID: 9296407
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients.
Bey P; Wilkinson PM; Resbeut M; Bourdin S; Le Floch O; Hahne W; Claverie N
Support Care Cancer; 1996 Sep; 4(5):378-83. PubMed ID: 8883232
[TBL] [Abstract][Full Text] [Related]
13. Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children.
Sukhani R; Pappas AL; Lurie J; Hotaling AJ; Park A; Fluder E
Anesth Analg; 2002 Nov; 95(5):1230-5, table of contents. PubMed ID: 12401599
[TBL] [Abstract][Full Text] [Related]
14. Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study.
Korttila K; Clergue F; Leeser J; Feiss P; Olthoff D; Payeur-Michel C; Wessel P; Nave S; Hahne W; Brown R
Acta Anaesthesiol Scand; 1997 Aug; 41(7):914-22. PubMed ID: 9265937
[TBL] [Abstract][Full Text] [Related]
15. Dolasetron decreases postoperative nausea and vomiting after breast surgery.
Abou Zeid H; Al-Gahamdi A; Abdul-Hadi M
Breast J; 2002; 8(4):216-21. PubMed ID: 12100113
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of post-operative nausea and vomiting. Randomised comparison of dolasetron versus dolasetron plus dexamethasone].
Piper SN; Triem JG; Röhm KD; Kranke P; Maleck WH; Boldt J
Anaesthesist; 2003 Feb; 52(2):120-6. PubMed ID: 12624696
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group.
Hesketh P; Navari R; Grote T; Gralla R; Hainsworth J; Kris M; Anthony L; Khojasteh A; Tapazoglou E; Benedict C; Hahne W
J Clin Oncol; 1996 Aug; 14(8):2242-9. PubMed ID: 8708713
[TBL] [Abstract][Full Text] [Related]
18. Oral granisetron for strabismus surgery in children.
Munro HM; D'Errico CC; Lauder GR; Wagner DS; Voepel-Lewis T; Tait AR
Can J Anaesth; 1999 Jan; 46(1):45-8. PubMed ID: 10078402
[TBL] [Abstract][Full Text] [Related]
19. Intravenous dolasetron mesilate in the prevention of postoperative nausea and vomiting in females undergoing gynecological surgery.
Diemunsch P; D'Hollander A; Paxton L; Schoeffler P; Wessel P; Navé S; Brown RA; Hahne WF
J Clin Anesth; 1997 Aug; 9(5):365-73. PubMed ID: 9257201
[TBL] [Abstract][Full Text] [Related]
20. Timing of administration of dolasetron affects dose necessary to prevent postoperative nausea and vomiting.
Korttila KT; Jokinen JD
J Clin Anesth; 2004 Aug; 16(5):364-70. PubMed ID: 15374558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
